TPG Nov 2024 35.000 put
| Previous close | 0.8000 |
| Open | 0.8000 |
| Bid | 0.8000 |
| Ask | 2.1000 |
| Strike | 35.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.8000 - 0.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 248 |
- Business Wire
K2 Medical Research and TPG Establish Partnership to Build a Leading Integrated Site Platform
SAN FRANCISCO & ORLANDO, Fla., June 17, 2024--TPG (NASDAQ: TPG), a leading global alternative asset management firm, today announced a significant strategic growth investment in K2 Medical Research ("K2" or the "Company"), an integrated clinical trial site platform specializing in central nervous system (CNS) trials for leading pharma and biotech sponsors. TPG is partnering with K2’s management team to continue building a world class research platform. Terms were not disclosed.
- Business Wire
TPG to Present at the Morgan Stanley U.S. Financials, Payments & CRE Conference
SAN FRANCISCO & FORT WORTH, Texas, May 29, 2024--TPG Inc. (NASDAQ: TPG), a leading global alternative asset management firm, announced today that Jon Winkelried, Chief Executive Officer, is scheduled to present at the Morgan Stanley U.S. Financials, Payments & CRE Conference on Tuesday, June 11, 2024 at 3:15 p.m. ET.
- Business Wire
TPG Reports First Quarter 2024 Results
SAN FRANCISCO & FORT WORTH, Texas, May 08, 2024--TPG Inc. (NASDAQ: TPG), a leading global alternative asset management firm, reported its unaudited first quarter 2024 results. TPG issued a full detailed presentation of its first quarter ended March 31, 2024 results, which can be viewed through the Investor Relations section of TPG’s website at shareholders.tpg.com.
